text
"['\nIX. 계열회사 등에 관한 사항\n1. 계열회사의 현황\n가. 해당 기업집단의 명칭 및 소속 회사의 명칭\xa0\xa0- 기업집단 명칭 : 메리츠금융그룹\xa0 - 소속 회사의 명칭 (2020년 9월 30일 기준)\n지주회사\n기업집단 소속회사\n상장여부\n사업자등록번호\n(주)메리츠금융지주(220-88-14824)\n\xa0메리츠증권(주)\n상장\n116-81-22502\n\xa0메리츠화재해상보험(주)\n상장\n116-81-03752\n\xa0메리츠캐피탈(주)\n비상장\n107-87-67865\n\xa0메리츠자산운용(주)\n비상장\n107-87-08658\n\xa0메리츠대체투자운용(주)\n비상장\n186-86-00370\n\xa0메리츠코린도보험\n비상장(해외)\n(해외현지법인)\n나.\xa0계열회사간의 지배ㆍ종속 및 출자 현황을 파악할 수 있는 계통도\n그룹 지배구조 현황(2020.9.30 기준)\n다. 계열회사 중 회사의 경영에 직접 또는 간접으로 영향력을 미치는 회사- 회사명 : (주)메리츠금융지주-\xa0내\xa0\xa0 용 : (주)메리츠금융지주는 당사의\xa047.06%\xa0지분을 보유한 최대주주\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 (해당 지분율은 보통주식 총수와 의결권부 우선주식수 기준) \n라. 회사와 계열회사간 임원 겸직 현황\n\xa0\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0(기준일 : 2020년 09월 30일)\n성\xa0 \xa0 명\n회사명\n직\xa0\xa0 책\n상근여부\n김 성 범\n메리츠캐피탈\n정보보호최고책임자\n상근(미등기)\n한 정 원\n메리츠금융지주\n브랜드홍보총괄\n상근(미등기)\n메리츠화재\n홍보본부장\n상근(미등기)\n2. 타법인출자 현황\xa0\n(기준일 :\xa0\n2020년 09월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n메리츠캐피탈 (비상장)\n2017.04.28\n종속회사\n700,180\n48,200,000\n100.0\n700,180\n-\n-\n-\n48,200,000\n100.0\n700,180\n6,394,698\n100,851\n한국거래소 (비상장)\n-\n지분투자\n84,815\n1,165,345\n5.8\n193,680\n-\n-\n28,033\n1,165,345\n5.8\n221,713\n9,203,978\n168,717\n한국증권금융 (비상장)\n-\n지분투자\n3,554\n681,367\n1.0\n11,462\n-\n-\n1,291\n681,367\n1.0\n12,753\n49,985,380\n136,980\n한국예탁결제원 (비상장)\n-\n지분투자\n2,797\n62,790\n0.6\n6,380\n2,995\n-312\n-\n65,785\n0.6\n6,068\n3,464,253\n48,904\n한국자금중개 (비상장)\n-\n지분투자\n200\n40,000\n2.0\n2,609\n-\n-\n81\n40,000\n2.0\n2,690\n98,799\n9,052\n국민행복기금 (비상장)\n2009.01.05\n지분투자\n237\n79\n0.0\n237\n-\n-\n-\n79\n0.0\n237\n539,957\n-86,497\n동경주일반산업단지㈜ (비상장)\n2013.02.27\n투자\n230\n23,000\n8.5\n-\n-\n-\n-\n23,000\n8.5\n-\n-\n-\n영통프로젝트 (비상장)\n2014.06.25\n출자\n250\n50,000\n5.0\n250\n-\n-\n-\n50,000\n5.0\n250\n23,158\n12,323\n에스엠신용정보주식회사 (비상장)\n2015.06.01\n투자\n415\n30,000\n2.4\n416\n-\n-\n-\n30,000\n2.4\n416\n28,768\n-1,800\n뉴스1 (비상장)\n2015.06.01\n투자\n300\n60,000\n5.0\n300\n-\n-\n-\n60,000\n5.0\n300\n18,409\n2,005\nSB개발프로젝트 (비상장)\n2015.09.25\n투자\n250\n50,000\n5.0\n250\n-\n-\n-\n50,000\n5.0\n250\n7,385\n-443\n화성도시PFV (비상장)\n2015.10.20\n투자\n750\n150,000\n15.0\n750\n-150,000\n-750\n-\n-\n-\n-\n8,981\n2,412\nIMM Design 벤처펀드 (비상장)\n2015.12.23\n투자\n320\n399\n1.9\n408\n-345\n-352\n-\n54\n2.3\n56\n13,798\n2,913\n아이피씨원주피에프브이㈜ (비상장)\n2016.03.31\n투자\n250\n25,000\n5.0\n250\n-\n-\n-\n25,000\n5.0\n250\n140,040\n-16,543\n에스지제십이호 기업재무안정 사모투자합자회사 (비상장)\n2016.08.11\n투자\n150\n150,000,000\n6.6\n311\n-149,999,000\n-311\n-\n1,000\n6.6\n-\n4,071\n9,206\n중앙제어 전환상환우선주 (비상장)\n2016.12.21\n투자\n648\n7,142\n2.4\n1,218\n-\n-\n52\n7,142\n2.4\n1,270\n29,543\n451\n올윈웨어 전환상환우선주 (비상장)\n2016.12.23\n투자\n1,142\n16,064\n3.6\n2,241\n5,722\n-241\n-\n21,786\n4.9\n2,000\n4,186\n-1,304\n범계역모비우스피에프브이 (비상장)\n2017.01.16\n투자\n525\n105,000\n10.5\n525\n-\n-\n-\n105,000\n10.5\n525\n134,776\n16,220\n지엠비바이오투자조합1호 (비상장)\n2017.02.15\n투자\n1,020\n1,020\n15.0\n1,043\n-\n-\n233\n1,020\n15.0\n1,276\n6,916\n-140\n목동피에프브이 (비상장)\n2017.03.09\n투자\n1,250\n250,000\n12.5\n704\n-\n-\n-704\n250,000\n12.5\n-\n3,005\n-2,003\n융복합게임 ""BTSG"" 프로젝트 펀드 (비상장)\n2017.04.14\n투자\n1,000\n1,000,000,000\n20.0\n-\n-\n-\n-\n1,000,000,000\n20.0\n-\n2,985\n4,932\n신한디스플레이신기술투자조합제1호 (비상장)\n2017.04.26\n투자\n1,500\n1,500,000,000\n14.4\n-\n-\n-\n-\n1,500,000,000\n14.4\n-\n217\n-10838\n전남 오룡지구 공동주택 개발사업 PFV (비상장)\n2017.06.19\n투자\n750\n150,000\n15.0\n750\n-\n-\n-\n150,000\n15.0\n750\n142,916\n23,105\n블루코어PFV(송도 6.8공구) (비상장)\n2017.08.03\n투자\n4,550\n910,000\n9.1\n4,550\n-\n-\n-\n910,000\n9.1\n4,550\n51,469\n678\n파워보이스 전환상환우선주 (비상장)\n2017.11.08\n투자\n563\n125,000\n3.0\n773\n-\n-\n50\n125,000\n3.0\n823\n15,268\n-2,094\n폴라리스 제7호 창업벤처전문 사모투자 합자회사 (비상장)\n2017.11.29\n투자\n477\n477,272,710\n6.5\n625\n-\n-\n-25\n477,272,710\n6.5\n600\n8,112\n634\n아시아그로쓰제1호사모투자합자회사 (비상장)\n2017.12.28\n투자\n5,000\n5,000,000,000\n45.5\n5,000\n-\n-\n-\n5,000,000,000\n45.5\n5,000\n10,473\n-283\n아틸라인프라제1호 사모투자합자회사 (비상장)\n2017.12.29\n투자\n2,000\n2,000,000,000\n28.6\n1,884\n-\n-\n259\n2,000,000,000\n28.6\n2,143\n6,790\n-1\n코리아오메가-티그리스투자조합1호 (비상장)\n2018.01.29\n투자\n500\n500,000,000\n5.6\n500\n-\n-\n-\n500,000,000\n5.6\n500\n8,833\n-85\n키움증권 전환상환우선주 (상장)\n2018.02.21\n투자\n30,000\n278,140\n1.1\n31,133\n-\n-\n1,999\n278,140\n1.1\n33,132\n31,924,466\n228,227\n글로벌바이오투자조합 (비상장)\n2018.03.28\n투자\n1,168\n1,167,841,944\n12.1\n1,168\n-387,032,202\n-387\n-\n780,809,742\n12.8\n781\n16,645\n7,266\n케이클라비스 마이스터 제삼십팔호 (비상장)\n2018.06.14\n투자\n900\n900,000,000\n81.8\n900\n-\n-\n-\n900,000,000\n81.8\n900\n1,082\n-18\n공평십오십육피에프브이 (비상장)\n2018.06.04\n투자\n1,600\n258,675\n19.6\n1,600\n-50,000\n-360\n-\n208,675\n15.8\n1,240\n259,711\n-14,596\n세븐트리글로벌제1호사모투자합자회사 (비상장)\n2018.04.20\n투자\n1,000\n1,000,000,000\n8.3\n1,030\n-\n-\n-5\n1,000,000,000\n8.3\n1,025\n9,974\n-259\n지엑스 신한인터베스트 제1호 사모투자합자회사 (비상장)\n2018.05.18\n투자\n5,000\n5,000,000,000\n3.6\n4,646\n-3,872,714,518\n-3,269\n-\n1,127,285,482\n3.6\n1,377\n131,237\n5,284\n제네시스북미파워기업1호 (비상장)\n2018.08.09\n투자\n7,270\n7,227,762,317\n15.5\n7,228\n42,079,885\n42\n-\n7,269,842,202\n15.5\n7,270\n46,029\n2,065\n제로웹 전환상환우선주 (비상장)\n2018.08.09\n투자\n987\n10,204\n0.4\n490\n91,836\n68\n-\n102,040\n3.6\n558\n1,447\n-1,384\n에스엘백시젠 전환상환우선주 (비상장)\n2018.09.20\n투자\n1,000\n2,087\n1.3\n1,000\n18,783\n-\n-\n20,870\n1.4\n1,000\n11,007\n-3,794\nKAI-열림 EV펀드 신기술조합 (비상장)\n2018.09.27\n투자\n1,000\n1,000\n4.8\n961\n-\n-\n16\n1,000\n4.8\n977\n14,832\n-172\n멘티스코 전환상환우선주 (비상장)\n2018.10.12\n투자\n1,000\n119,979\n6.6\n1,000\n-\n-\n-\n119,979\n6.6\n1,000\n7,457\n-6,965\n케이클라비스 마이스터 제오십일호 (비상장)\n2018.10.25\n투자\n1,000\n1,000,000,000\n16.2\n985\n-\n-\n5,108\n1,000,000,000\n16.2\n6,093\n6,065\n-94\n웰마커바이오 전환상환우선주 (비상장)\n2018.10.31\n투자\n1,000\n64,040\n0.5\n624\n-\n-\n10\n64,040\n0.5\n634\n40,677\n-34,381\n뉴웨이브메디컬투자조합 (비상장)\n2019.01.08\n투자\n1,000\n1,000,000,000\n32.4\n1,000\n-1,000,000,000\n-1,000\n-\n-\n-\n-\n3,162\n194\n서초아트피에프브이 (비상장)\n2019.01.14\n투자\n738\n73,750\n14.8\n738\n-\n-\n-\n73,750\n14.8\n738\n48,899\n-102\n와이바이오로직스 전환상환우선주 (비상장)\n2019.01.22\n투자\n1,460\n112,308\n1.0\n1,783\n-\n-\n239\n112,308\n1.0\n2,022\n37,335\n-11,197\n오에스티파트너스 (비상장)\n2019.01.29\n투자\n1,000\n100,000\n12.5\n1,000\n-50,000\n-500\n-\n50,000\n12.5\n500\n91,284\n-16,798\n파라투스에스피사모투자합자회사 (비상장)\n2019.01.31\n투자\n1,500\n1,500,000,000\n3.1\n1,487\n-\n-\n-15\n1,500,000,000\n3.1\n1,472\n47,567\n-550\n피에이치파마 전환상환우선주 (비상장)\n2019.02.15\n투자\n1,000\n42,570\n0.6\n994\n-\n-\n76\n42,570\n0.6\n1,070\n23,049\n-40,396\n엔피글로벌성장제2호 PEF (비상장)\n2019.02.21\n투자\n2,000\n2,000,000,000\n11.0\n2,214\n-\n-\n26\n2,000,000,000\n11.0\n2,240\n2,502\n-62\n코리아오메가-레드우드글로벌헬스케어투자조합 (비상장)\n2019.02.22\n투자\n1,000\n10\n11.0\n983\n10\n989\n-\n20\n8.8\n1,972\n8,903\n-200\n와이앤피성장지원제1호 신기술출자 (비상장)\n2019.02.26\n투자\n1,000\n100,000\n13.9\n1,000\n-100,000\n-1,000\n-\n-\n-\n-\n7,228\n28\n케이디비씨-티알(KDBC-TR) 신기술사업투자조합2호 (비상장)\n2019.03.07\n투자\n2,000\n2,000,000,000\n12.9\n2,153\n-\n-\n-86\n2,000,000,000\n12.9\n2,067\n16,811\n1,125\n센트로이드제3호그로쓰 창업벤처전문 사모투자합자회사 (비상장)\n2019.04.09\n투자\n1,000\n1,000,000,000\n17.2\n961\n-\n-\n-3\n1,000,000,000\n17.2\n958\n5,522\n-280\n라이노스-메리츠 신기술사업투자조합 (비상장)\n2019.04.10\n투자\n2,000\n2,000,000,000\n16.6\n2,000\n-\n-\n-\n2,000,000,000\n16.6\n2,000\n14,489\n2,453\n한양액시스바이오 신기술투자조합 (비상장)\n2019.04.17\n투자\n1,000\n1,000,000,000\n19.1\n1,000\n-550,000,000\n-460\n-\n450,000,000\n19.1\n540\n5,211\n-39\n이수(ISU) 인터베스트-KDBC 신기술조합1호 (비상장)\n2019.04.12\n투자\n1,000\n1,000,000,000\n2.4\n979\n-406,048,920\n-39\n-\n593,951,080\n2.4\n940\n38,571\n-3,440\n브릭-오비트_4호_신기술사업투자조합 (비상장)\n2019.04.30\n투자\n1,000\n10\n8.3\n992\n-\n-\n16\n10\n8.3\n1,008\n11,853\n-146\n힉스프런티어주식회사 (비상장)\n2019.05.13\n투자\n0\n19\n19.0\n0\n-\n-\n-\n19\n19.0\n0\n2,502\n-62\n원신한신기술투자조합1부칼라팍 (비상장)\n2019.05.29\n투자\n1,000\n1,000,000,000\n4.4\n952\n-\n-\n10\n1,000,000,000\n4.4\n962\n22,263\n-387\n메딕콘 전환상환우선주 (비상장)\n2019.06.07\n투자\n1,000\n17,053\n3.1\n1,000\n-\n-\n-\n17,053\n3.1\n1,000\n7,251\n-3,055\n메리츠-코레이트 신기술사업조합 (비상장)\n2019.06.12\n투자\n1,637\n1,636,852,917\n14.6\n1,637\n-1,636,852,917\n-1,637\n-\n-\n-\n-\n13,822\n2,637\n우리노틱신기술투자조합 (비상장)\n2019.06.27\n투자\n500\n500\n8.6\n491\n-\n-\n10\n500\n8.6\n501\n5,683\n-119\n아세안플랫폼신기술조합 제1호 (비상장)\n2019.07.10\n투자\n1,000\n1,000,000,000\n10.4\n1,000\n-\n-\n-\n1,000,000,000\n10.4\n1,000\n9,550\n-100\n메리츠비하이신기술조합 (비상장)\n2019.08.26\n투자\n200\n200,000,000\n3.8\n200\n-\n-\n-\n200,000,000\n3.8\n200\n5,447\n237\n티케이빌드 (비상장)\n2019.09.19\n투자\n0\n15\n15.0\n0\n-\n-\n-\n15\n15.0\n0\n10,150\n-128\n메리츠디에스 신기술조합 (비상장)\n2019.10.08\n투자\n1,000\n1,000,000,000\n22.7\n1,000\n-\n-\n-\n1,000,000,000\n22.7\n1,000\n4,379\n-21\n라이노스-메리츠2호 신기술사업투자조합 (비상장)\n2019.11.06\n투자\n800\n800,000,000\n16.9\n800\n-\n-\n-\n800,000,000\n16.9\n800\n4,723\n-4\n에스티캐피탈 신기술조합 제십일호 (비상장)\n2019.11.07\n투자\n500\n500\n9.6\n500\n-\n-\n-\n500\n9.3\n500\n5,173\n-17\n디에이밸류 길트엣지글로벌바이오 제1호 (비상장)\n2019.11.11\n투자\n500\n500,000,000\n14.7\n500\n-\n-\n-\n500,000,000\n14.7\n500\n3,391\n-9\n넥스텍 제1호 신기술사업투자조합 (비상장)\n2019.11.14\n투자\n1,000\n1,000,000,000\n3.1\n1,000\n-\n-\n-6\n1,000,000,000\n3.1\n994\n32,001\n-37,281\n코세스지티 전환상환우선주 (비상장)\n2019.11.22\n투자\n500\n5,263\n2.6\n500\n-\n-\n-\n5,263\n2.6\n500\n4,480\n-1,923\n마곡마이스피에프브이㈜ (비상장)\n2019.12.10\n투자\n625\n125,000\n12.5\n625\n-\n-\n-\n125,000\n12.5\n625\n117,376\n-3,624\n브릭-오비트 8호 신기술사업투자조합 (비상장)\n2019.12.12\n투자\n1,000\n10\n21.3\n1,000\n-\n-\n-\n10\n21.3\n1,000\n4,969\n-3\n청라로지스틱스 (비상장)\n2019.12.13\n투자\n0\n19\n19.0\n-\n-\n-\n-\n19\n19.0\n-\n13,024\n-463\n티제이더블유제이호 사모투자합자회사 (비상장)\n2019.12.17\n투자\n800\n800,000,000\n2.0\n800\n-30,000,000\n-30\n-\n770,000,000\n2.0\n770\n40,000\n-0\n주식회사 티에스티홀딩스 우선주 (비상장)\n2019.12.19\n투자\n20\n2,000\n6.7\n20\n-\n-\n-\n2,000\n6.7\n20\n53622\n-1629\n케이씨지아이 제1호의12 PEF (비상장)\n2019.12.20\n투자\n20,000\n20,000,000,000\n39.9\n20,000\n-\n-\n-\n20,000,000,000\n39.9\n20,000\n50,077\n-36\n엔피성장 제6호 사모투자합자회사 (비상장)\n2019.12.20\n투자\n1,000\n1,000,000,000\n1.2\n1,000\n-\n-\n-17\n1,000,000,000\n1.2\n983\n430,729\n-6,514\n충무로피에프브이 (비상장)\n2020.01.10\n투자\n600\n-\n-\n-\n60,000\n600\n-\n60,000\n12.0\n600\n4,539\n-462\n주식회사 테이크원컴퍼니 (비상장)\n2020.01.15\n투자\n1,000\n-\n-\n-\n1,373\n1,076\n-\n1,373\n1.0\n1,076\n8,803\n1,051\n금실개발㈜ (비상장)\n2020.01.20\n투자\n30\n-\n-\n-\n6,000\n30\n-\n6,000\n10.0\n30\n-\n-\n주식회사 건창 (비상장)\n2020.02.10\n투자\n4\n-\n-\n-\n833\n4\n-\n833\n16.7\n4\n24\n-1\n주식회사 예도개발 (비상장)\n2020.02.10\n투자\n4\n-\n-\n-\n833\n4\n-\n833\n16.7\n4\n24\n-1\n가하유앤아이 (비상장)\n2020.02.24\n투자\n10\n-\n-\n-\n2,000\n10\n-\n2,000\n16.7\n10\n12,111\n-3,309\n한강랜드마크피에프브이 (비상장)\n2020.02.28\n투자\n580\n-\n-\n-\n116,000\n580\n-\n116,000\n11.6\n580\n-\n-86\n다온종합건설 (비상장)\n2020.02.28\n투자\n2\n-\n-\n-\n380\n2\n-\n380\n19.0\n2\n5,294\n49\n마곡씨피포피에프브이 (비상장)\n2020.03.11\n투자\n250\n-\n-\n-\n50,000\n250\n-\n50,000\n5.0\n250\n4,971\n-29\n이앤에프코너스톤엔젤 투자조합 (비상장)\n2020.03.20\n투자\n1,000\n-\n-\n-\n1,000,000,000\n987\n-\n1,000,000,000\n6.3\n987\n5,000\n-\n갈매피에프브이 (비상장)\n2020.05.07\n투자\n975\n-\n-\n-\n195,000\n975\n-\n195,000\n19.5\n975\n4842\n-708\n오셔큐제일차 (비상장)\n2020.06.15\n투자\n0\n-\n-\n-\n2\n-\n-\n2\n50.0\n-\n-\n-\n어썸 넥스트 제너레이션 제1호 (비상장)\n2020.07.02\n투자\n300\n-\n-\n-\n300,000,000\n300\n-\n300,000,000\n18.5\n300\n-\n-\n뉴웨이브신기술금융조합제2호 (비상장)\n2020.07.10\n투자\n1,500\n-\n-\n-\n1,500,000,000\n1,500\n-\n1,500,000,000\n14.7\n1,500\n-\n-\n송강산업개발 (비상장)\n2020.07.15\n투자\n30\n-\n-\n-\n6,000\n30\n-\n6,000\n10.0\n30\n-\n-\n(주)대산이엔지산업건설 (비상장)\n2020.07.23\n투자\n3,000\n-\n-\n-\n-\n3,000\n-\n-\n-\n3,000\n-\n-\n신한헬스케어투자조합제5호 (비상장)\n2020.08.20\n투자\n1,000\n-\n-\n-\n1,000,000,000\n999\n-1\n1,000,000,000\n10.0\n999\n-\n-\n디씨에이엠피에프브이 (비상장)\n2020.09.15\n투자\n500\n-\n-\n-\n100,000\n500\n-\n100,000\n10.0\n500\n-\n-\n킹고 바이오 그로스 제3호 투자조합 (비상장)\n2020.09.24\n투자\n1,000\n-\n-\n-\n1,000\n1,000\n-\n1,000\n18.2\n1,000\n-\n-\n마그나 디 글로벌 헬스케어 1호 사모투자 (비상장)\n2020.09.25\n투자\n1,000\n-\n-\n-\n1,000,000,000\n1,000\n-\n1,000,000,000\n15.4\n1,000\n-\n-\n메리츠알파뷰신기술금융조합 제1호 (비상장)\n2020.09.25\n투자\n500\n-\n-\n-\n500,000,000\n500\n-\n500,000,000\n10.4\n500\n-\n-\n합 계\n67,413,145,246\n-\n1,042,370\n-2,690,259,250\n3,798\n36,647\n64,722,885,996\n-\n1,082,816\n-\n-\n주1) 기초 또는 기말 현재 장부가액 1억원을 초과하거나 지분율 5% 초과분을 대상으로 작성하였습니다.(당기손익 공정가치측정금융자산(주식)은 제외하였습니다.)주2) 시장성없는 지분증권 중 한국거래소, 한국증권금융, 한국예탁결제원, 한국자금중개 등은 독립적인 외부평가기관(FN자산평가)의 전문적인 판단에 근거한 합리적인 평가 모형과 적절한 추정치를 사용하여 산정한 금액을 공정가치로 보아 평가하였습니다.\n']"
